Chairman of NKCL Bio Group, Shin Dong-Hwa (center left) and the director of Qingdao Orthopaedic Hospital, Dong Xiao-Guang (center right) had signed MOA on 14th January 2020. NKCL Bio Group is a Korean Bio-company that researches NK Immune Cell Treatment using NK cells. Starting with the construction ...
Shin Dong hwa, chairman of NKCL bio Group (second photo, third from left) visited Qingdao Yishengjian General Hospital (first photo) and met the hospital director, Dong Xiaoguang (second picture, second from left) to sign MOA. After NKCL Bio Group has successfully celebrated its construction start ce...
NKCL Bio Group Inc. (hereinafter called ‘NKCL Bio’) held a construction start ceremony for ‘NK Cell GMP Automated Culture System’ in Dongtan New City, Hwaseong, Gyeonggi Province, on December 30th. Chairman Shin Dong-Hwa, giving celebration speech on construction start ceremony of NK Cell GMP Aut...
Chairman Shin Dong-hwa of NKCL to Win the Grand Award in “10 People Who Illuminated Korea 2019: New Intellectuals” Shin Dong-hwa, chairman of NKCL, was honored with the grand award in the ceremony for “10 People Who Illuminated Korea 2019: New Intellectuals” NKCL Chairman Shin Dong-Hwa, the recip...
NKCL Bio Group launches ‘Dried Bio-cellulose Mask pack’ on Christmas Eve NKCL Bio Group Inc. (referred to as ‘NKCL Bio’) launched on 24th December, 4 types of ‘NKCL Dry Bio-Cellulose Mask Pack’ in which a medical ingredient, Dried Bio-cellulose, was used on the production. NKCL Bio is a bio ent...
NKCL Bio Group 'Personalized Genetic Analysis Service, DNA Navigator' and Specialized N.K. Cosmetics Are Close to Launch NKCL Bio Group is a South Korean bio company that provides immune-cell treatment using NK cells and runs an immune-care platform. Through NKCL International, a distribution and sal...
NKCL Bio Group Targets Global Immune Cell Treatment Market worth $100 billion by Differentiating Its Technology Competitiveness NKCL Bio Group Inc. (hereinafter referred to as 'NKCL Bio Group') is a Korean bio company that researches and develops immune cell treatment using NK immune cells. The compa...
NKCL Bio Group Inc. is a developer of platform-based commerce and block-chain started as a laboratory that researched NK immune cell for more than 11 years. GK global group who has NKCL Bio Group Inc. as its subsidiary, has carried businesses in major cities in China before, by managing GK Medical Ce...
[NKCL] GK Global Group works in earnest on listing of NKCL International on the London Stock Exchange. GK Global Group, the parent company of NKCL, took a first step for NKCL International (NKCL Distribution and Sales Corporation) to be listed on the mainboard of the London Stock Exchange. GK Global ...
GK Global Group Chairman Dong-Hwa Shin attended the Asia Digital Economy Industry Summit (ADES) hosted by Hong Kong's Asian Television (aTV) to meet with the world's top IT industry leaders and he had time to announce the theme. The ADES, held in Hong Kong on September 19, was a summit of digital cur...